<table width="80%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 1. Pharmacokinetic parameters of buprenorphine after the administration of 4 mg, 8 mg, and 16 mg buprenorphine and naloxone sublingual tablet doses and 16 mg buprenorphine HCl sublingual tablets dose (mean [%CV])</caption>
<col align="left" span="1" valign="middle" width="20%"></col>
<col align="center" span="1" valign="middle" width="20%"></col>
<col align="center" span="1" valign="middle" width="20%"></col>
<col align="center" span="1" valign="middle" width="20%"></col>
<col align="center" span="1" valign="middle" width="20%"></col>
<tbody>
<tr>
<th colspan="1">Pharmacokinetic Parameter </th>
<th colspan="1">buprenorphine and naloxone sublingual tablets 4 mg</th>
<th colspan="1">buprenorphine and naloxone sublingual tablets 8 mg</th>
<th colspan="1">buprenorphine and naloxone sublingual tablets 16 mg</th>
<th colspan="1">Buprenorphine HCl sublingual tablets 16 mg</th>
</tr>
<tr>
<td>C<sub>max</sub>, ng/mL</td>
<td>1.84 (39)</td>
<td>3.0 (51)</td>
<td>5.95 (38)</td>
<td>5.47 (23)</td>
</tr>
<tr>
<td>AUC <sub>0-48</sub>, hour. ng/mL</td>
<td>12.52 (35)</td>
<td>20.22 (43)</td>
<td>34.89 (33)</td>
<td>32.63 (25)</td>
</tr>
</tbody>
</table>